Autoimmune Disease Diagnosis Market Analysis, Latest Developments And Objectives Report 2033

Overview and Scope
Autoimmune diseases diagnosis are the diseases in which the production of antibodies takes place in the body which attacks and destroys own healthy cells in the body. These include Crohn's disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome, and are diagnosed by immunological tests.

Sizing and Forecast
The autoimmune disease diagnosis market size has grown strongly in recent years. It will grow from $5.56 billion in 2023 to $6.05 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising incidence of autoimmune diseases, emerging markets growth, increased healthcare expenditure, and high prevalence in women.

The autoimmune disease diagnosis market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increased funding for autoimmune (ai) diagnostics, faster economic growth, growing awareness about autoimmune diseases, and biomarker discovery. Major trends in the forecast period include partnering with other players, investing in with artificial intelligence companies, collaborating with the government, and developing at-home rapid test kits.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Segmentation & Regional Insights
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By End User: Clinical Laboratories, Hospitals, Others
3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

North America was the largest region in the autoimmune disease diagnosis market in 2023. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

Major Driver Impacting Market Growth
A high incidence of autoimmune diseases contributed to the growth of the autoimmune disease diagnosis market. For instance, in February 2023, according to Multiple Sclerosis Australia, an Australia-based national non-profit organization dedicated to research and advocacy on behalf of those aggrieved by multiple sclerosis, there were 33,335 Multiple Sclerosis patients in Australia in 2021, a 30% (7,728) increase over the preceding four years (25,607). Therefore, increasing incidence of autoimmune diseases across the globe is driving the growth of the autoimmune disease diagnosis market.

Key Industry Players
Major companies operating in the autoimmune disease diagnosis market report are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMérieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith’s Medical India Pvt Ltd, Agappe Diagnostics Ltd, Accord Medical Products Private Limited, Terumo Corporation, Olympus Medical Systems Corporation, Canon Medical Systems Corporation, Hitachi Group, Nihon Koden Corporation, Sanko Manufacturing Co.,Ltd, Fukuda Denshi, Metran Co., Ltd , Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Fresenius Medical Care, Novartis, Merck, Bayer, Medtronic, Draegerwerk AG, Getinge Group, Themis Bioscience, Stryker, Apotex, Bausch Health, Pfizer, HYCOR Biomedical, Exagen Inc, Kronus, Inova Diagnostics, Masimo, Teleflex Inc, 3M, Johnson & Johnson, Becton Dickinson, B. Braun Medical Inc, ResMed Inc

The autoimmune disease diagnosis market report table of contents includes:
1. Executive Summary
2. Autoimmune Disease Diagnosis Market Characteristics
3. Autoimmune Disease Diagnosis Market Trends And Strategies
4. Autoimmune Disease Diagnosis Market - Macro Economic Scenario
5. Global Autoimmune Disease Diagnosis Market Size and Growth

....

32. Global Autoimmune Disease Diagnosis Market Competitive Benchmarking
33. Global Autoimmune Disease Diagnosis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Autoimmune Disease Diagnosis Market
35. Autoimmune Disease Diagnosis Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model